Prosecution Insights
Last updated: April 19, 2026

BENEVOLENTAI BIO LIMITED

5 pending office actions

Portfolio Summary

5
Total Pending OAs
1
Final Rejections
4
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17997448 PATIENT STRATIFICATION USING LATENT VARIABLES NEGIN, RUSSELL SCOTT 1686 Non-Final OA Oct 28, 2022
17904911 SELECTING A CELL LINE FOR AN ASSAY SANFORD, DIANA PATRICIA 1687 Non-Final OA Aug 24, 2022
17782058 PRIORITISING BIOLOGICAL TARGETS PLAYER, ROBERT AUSTIN 1686 Non-Final OA Jun 02, 2022
17623929 IDENTIFYING ONE OR MORE COMPOUNDS FOR TARGETING A GENE AUGER, NOAH ANDREW 1687 Non-Final OA Dec 30, 2021
17276675 MACHINE LEARNING FOR PROTEIN BINDING SITES SABOUR, GHAZAL 1686 Final Rejection Mar 16, 2021

Managing BENEVOLENTAI BIO LIMITED's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month